Pancreatic Cancer Clinical Trials

Clinical Trial: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Clinical Trial: Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer

Clinical Trial: Stool Testing for Pancreatic Cancer

Clinical Trial: Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder

Clinical Trial: A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer

Clinical Trial: Studying Biomarkers in Patients With Pancreatic Cancer

Clinical Trial: Pancreatic Cancer Genetic Epidemiology (PACGENE) Study

Clinical Trial: Vaccine Study for Surgically Resected Pancreatic Cancer

Clinical Trials: APRiCOT-P: Study to Evaluate the Safety and Efficacy of Apricoxib With Gemcitabine and Erlotinib in the Treatment of Patients With Advanced Pancreatic Cancer (TP2001-203)

Clinical Trials: Phase II Study of Coagulation Factor VIIa Inhibitor PCI-27483 in Pancreatic Cancer Patients Receiving Treatment With Gemcitabine, Part A

Clinical Trials: Phase I Study of Low-Dose Fractionated Radiotherapy as a Chemosensitizer for Gemcitabine and Erlotinib in Patients With Locally Advanced or Limited Metastatic Pancreatic Cancer

Clinical Trials: A Phase 1b/2 Study to Evaluate the Safety and Efficacy of AMG 655 or AMG 479 in Combination With Gemcitabine as First-Line Therapy for Metastatic Pancreatic Cancer

Clinical Trials: Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer

Clinical Trial: Vaccine Study for Surgically Resected Pancreatic Cancer

Clinical Trial: Pancreatic Cancer Genetic Epidemiology (PACGENE) Study

For a complete listing of clinical trials pertaining to Pancreatic Cancer via ClinicalTrials.gov, click here.

Pancreatic Cancer News

Genetic culprit in pancreatic cancer risk identified

ACS annual report says cancer mortality is decreasing

Gene Involved in Familial Pancreatic Cancer Identified

How would I know if I may have pancreatic cancer?

Everolimus combination improved progression-free survival in neuroendocrine tumors

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions